日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic review

转移性激素敏感性前列腺癌随机对照试验中与健康相关的生活质量结局：系统评价

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102914
Osanto, Susanne; Vliert-Bout, Anne-Laurien van de; Gomez de Segura, Cristina Alvarez; Efficace, Fabio; Sparano, Francesco; Willemse, Peter-Paul; Schoones, Jan; Cohen, Adam; Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

Quantitative ultrasound of the calcaneus (QUS): A valuable tool in the identification of patients with non-metastatic prostate cancer requiring screening for osteoporosis

跟骨定量超声（QUS）：识别需要进行骨质疏松症筛查的非转移性前列腺癌患者的有效工具

期刊:Bone Reports
影响因子:2.6
doi:10.1016/j.bonr.2023.101679
Nieuwkamer, B B; Vrouwe, J P M; Willemse, P M; Nicolai, M P J; Bevers, R F M; Pelger, R C M; Hamdy, N A T; Osanto, S
肿瘤
肿瘤免疫
代谢
骨质疏松
前列腺癌
发表日期：2023
文献求助 收藏

Risk of osteoporosis in testicular germ cell tumour survivors: A systematic review of the literature

睾丸生殖细胞肿瘤幸存者骨质疏松症风险：文献系统综述

期刊:BJUI Compass
影响因子:1.9
doi:10.1002/bco2.183
Vrouwe, Josephina P M; Hennus, Pauline M L; Hamdy, Neveen A T; Osanto, Susanne; Willemse, Peter-Paul M
肿瘤
肿瘤免疫
代谢
骨质疏松
细胞生物学
发表日期：2023
文献求助 收藏

An Educational Need Regarding Treatment-Related Infertility and Fertility Preservation: a National Survey Among Members of the Dutch Society for Medical Oncologists

关于治疗相关性不孕症和生育力保存的教育需求：荷兰肿瘤内科医师协会成员的一项全国性调查

期刊:Journal of Cancer Education
影响因子:1.3
doi:10.1007/s13187-021-02084-1
Krouwel, E M; Birkhoff, E M L; Nicolai, M P J; Osanto, S; Putter, H; Pelger, R C M; Elzevier, H W
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

In Reply: Neoadjuvant TKI Study in Early- and Intermediate Stage Hepatocellular Carcinoma

回复：早期和中期肝细胞癌的新辅助TKI研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac215
Osanto, Susanne; Woei-A-Jin, F J Sherida H; Coenraad, Minneke J; Weijl, Nir I; Burgmans, Mark C; Burggraaf, Jacobus
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy

结合4/5型模式百分比（IQ-Gleason）和筛状结构（cGrade）的前列腺癌分级系统可提高根治性前列腺切除术后预后的预测准确性。

期刊:Virchows Archiv
影响因子:3.1
doi:10.1007/s00428-022-03301-y
Seyrek, Neslisah; Hollemans, Eva; Andrinopoulou, Eleni-Rosalina; Osanto, Susanne; Pelger, Rob C M; van der Poel, Henk G; Bekers, Elise; Remmers, Sebastiaan; Schoots, Ivo G; van Leenders, Geert J L H
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients

根治性前列腺切除术中筛状结构可预测 Gleason 评分 8 分的前列腺癌患者的肿瘤学预后

期刊:Modern Pathology
影响因子:5.5
doi:10.1038/s41379-020-0625-x
Hollemans, Eva; Verhoef, Esther I; Bangma, Chris H; Rietbergen, John; Osanto, Susanne; Pelger, Rob C M; van Wezel, Tom; van der Poel, Henk; Bekers, Elise; Helleman, Jozien; Roobol, Monique J; van Leenders, Geert J L H
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients

格里森评分5级的粉刺性坏死与接受手术的前列腺癌患者较差的临床预后相关。

期刊:Modern Pathology
影响因子:5.5
doi:10.1038/s41379-021-00860-4
Hansum, Tim; Hollemans, Eva; Verhoef, Esther I; Bangma, Chris H; Rietbergen, John; Osanto, Susanne; Pelger, Rob C M; van Wezel, Tom; van der Poel, Henk; Bekers, Elise; Helleman, Jozien; Remmers, Sebastiaan; van Leenders, Geert J L H
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study

肝细胞癌局部治疗前采用血管生成抑制剂多维替尼进行新辅助治疗：一项 II 期研究

期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13901
Woei-A-Jin, F J Sherida H; Weijl, Nir I; Burgmans, Mark C; Fariña Sarasqueta, Arantza; van Wezel, J Tom; Wasser, Martin N J M; Coenraad, Minneke J; Burggraaf, Jacobus; Osanto, Susanne
肿瘤
肿瘤免疫
Angiogenesis
细胞生物学
血管生成
发表日期：2021
文献求助 收藏

An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer

一项探索性首次人体研究，旨在研究脂质体地塞米松在转移性去势抵抗性前列腺癌患者中，间隔 2 周和 1 周给药的药代动力学和安全性。

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.845
Vrouwe, Josephina P M; Kamerling, Ingrid M C; van Esdonk, Michiel J; Metselaar, Josbert M; Stuurman, Frederik E; van der Pluijm, Gabri; Burggraaf, Jacobus; Osanto, Susanne
前列腺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏